Focus
pharmacogenomics
MHRA to Use Genetic Screening to Investigate Bleeds Caused by Blood Thinners
The Yellow Card Biobank will form part of a more individualised approach to medicine, regulator says, as it comes under fire from a group of parliamentarians.
